Balabandere Cad. No:14 34460
Brief Description of the Company
Sanovel, a 100% Turkish capitalized company, operates in the pharmaceutical industry for over 30 years, and has created a distinguished name for having a dynamic and innovative structure .
Sanovel has 2500 employees with having one of the largest sales&marketing team in Turkey. As of 2016, the company has growth 3 times higher than the total market also by adding a considerable number of first to market generics to its portfolio for 2017.
Closely following the developments in the world, Sanovel is the leading company in Turkey on investing and developing value added branded generics , high technology products and also device included respiratory products. As a result of these investments, Sanovel accomplished to be the first Turkish firm to ever have an approved patent from the American Patent Office. Sanovel has earned the right to preserve the American patents of the four medical formulations until 2033.
Sanovel has an EU GMP approved facility with a 60.000 sqm and capable of manufacturing all pharmaceutical dosage forms. Sanovel has 148 branded generics in its portfolio and exist in both local and international markets with this large protfolio. Export operations have started in 2005 and ongoing with a significant growth every year. Spain, Russia, Ukraine, CIS, Balkan States, LATAM, South Asia, South Africa and MENA are some of the regions that Sanovel has either strong partnerships or its own sales&marketing teams.
With the goal of existence in all international markets, Sanovel will penetrate to US market in 2018 with a strong portfolio.
Annual Production Capacity
300 million boxes
Turkey, Germany, Spain, Ukraine, GCC, Russia
ISO 14001, OHSAS 18001, Occupational Health and Safety Management
Number of Employees